Showing results (2141-2150 of 2,317) with videos related to
Sort By:
Pageof 232
Cancer Immunology, Immunotherapy : CII|May 10, 2024
Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket studyShengxiang Ren, Anwen Xiong, Jia Yu, et al.European Journal of Cancer (Oxford, England : 1990)|March 13, 2024
A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanomaXiaoting Wei, Zhengyun Zou, Weizhen Zhang, et al.Open Forum Infectious Diseases|March 30, 2026
Informing the Value of "Boosting" Immunocompetent Adults based on Immune Responses Among US Service Members to SARS-CoV-2 Variants in Late 2024Huy C Nguyen, Li Pan, Kerri G Lal, et al.Journal of Magnetic Resonance Imaging : JMRI|April 29, 2015
Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole-body PET/MR: Correlation with pathological prognostic factorsI-Lun Shih, Ruoh-Fang Yen, Chi-An Chen, et al.Hepatology (Baltimore, Md.)|December 28, 2016
Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in miceGuojun Hou, Lei Chen, Gang Liu, et al.BMC Medicine|October 25, 2022
Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trialDan Liu, Jun Zhou, Yongsheng Wang, et al.EMBO Molecular Medicine|September 29, 2021
A homozygous R148W mutation in Semaphorin 7A causes progressive familial intrahepatic cholestasisQiong Pan, Gang Luo, Jiaquan Qu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 5, 2023
Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized StudyEverett E Vokes, Francoise Mornex, Ahmet Sezer, et al.Hepatology (Baltimore, Md.)|March 19, 2021
Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma-Immune Humanized Mouse ModelYue Zhao, Jiaxu Wang, Wai Nam Liu, et al.Cell Reports|March 30, 2022
PTIP governs NAD+ metabolism by regulating CD38 expression to drive macrophage inflammationQifan Wang, Jin Hu, Guoqiang Han, et al.Pageof 232